AZ13705339（Cat No.:I043737）is a selective small molecule inhibitor designed to target specific proteins involved in cancer cell proliferation and survival. It works by modulating critical signaling pathways, disrupting the growth and spread of tumor cells. AZ13705339 has shown potential in preclinical studies for treating a range of cancers, including solid tumors and hematologic malignancies. Its targeted approach aims to minimize off-target effects, offering a promising therapeutic strategy for cancers that are resistant to conventional treatments. Research is ongoing to evaluate its efficacy, safety, and potential clinical application in oncology.